New cancer immunotherapy drugs rapidly reach patients after approval
The majority of patients eligible for cancer drugs known as checkpoint inhibitors received treatment within months of FDA approval, according to a new study.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news
More News: Cancer | Cancer & Oncology | Immunotherapy | Science | Study | Universities & Medical Training | Yale